Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK
J Infect
.
2021 Apr;82(4):e8-e10.
doi: 10.1016/j.jinf.2021.01.007.
Epub 2021 Jan 17.
Authors
Julian W Tang
1
,
Oliver T R Toovey
2
,
Kirsty N Harvey
2
,
David D S Hui
3
Affiliations
1
Respiratory Sciences, University of Leicester, 5/F Sandringham Building, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, United Kingdom. Electronic address: julian.tang@uhl-tr.nhs.uk.
2
Clinical Microbiology, Leicester Royal Infirmary, Leicester, United Kingdom.
3
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.
PMID:
33472093
PMCID:
PMC7813514
DOI:
10.1016/j.jinf.2021.01.007
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Humans
SARS-CoV-2*
Spike Glycoprotein, Coronavirus
United Kingdom / epidemiology
Substances
Spike Glycoprotein, Coronavirus